Condition: Healthy Infants · Sponsor: Hvidovre University Hospital
The BABIES II study is a single-center, randomized, double-blinded, placebo-controlled study in newborns with an 8½ months intervention period from 14 days of age to 9 months of age followed by a 3-months short-term follow-up period until 1 year of age and a possible long-term follow-up until 18 years of age. The study will evaluate the effect of supplementation with a probiotic strain on different health outcomes.
This description comes directly from the study's public registry record.
Sofie Ingdam Halkjær, MSc, PhD · +45 38 62 38 62 · sofie.ingdam.halkjaer@regionh.dk
Always discuss trial participation with your own doctor first.
| Hvidovre Hospital | Hvidovre, Region Sjælland, Denmark | Recruiting |
| Center for Klinisk Mikrobiom Forskning, Gastroenheden og Klinisk Mikrobiologisk Afdeling | Hvidovre, Denmark | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07054216